SYS-CON MEDIA Authors: Sandi Mappic, Eric Brown, RealWire News Distribution, Kevin Benedict, Jason Bloomberg

News Feed Item

Court Rules in Favor of Ivera Medical in False Advertising Lawsuit, Denies Catheter Connections Motion

SAN DIEGO, CA -- (Marketwired) -- 02/26/14 -- Ivera Medical Corporation, headquartered in San Diego, CA, announced that the U.S. District Court for the Southern District of California ruled in its favor and against Catheter Connections in its false advertising and unfair competition lawsuit. The suit was filed under the Federal Lanham Act, 15 U.S.C. §1125(a), et al. and California Bus. & Prof. Code §17200, et seq., Case No. 3:13-cv-2452W RBB.

The Ivera suit claims that Catheter Connections falsely represented to the United States government that its DualCap Solo product was made in the United States, when in fact it was made in China. Catheter Connections moved to dismiss the claim, but the Court denied the motion, stating in part that "[t]he act of describing its product as made in the United States may have been false or at least misleading."

The suit further states that Ivera has been damaged due to these acts of false advertising and unfair competition and will continue to suffer irreparable injury unless Catheter Connections' activities are enjoined.

"We are pleased with the Court's denial of Catheter Connections' motion, and look forward to litigating this issue in court," said Bob Rogers, CEO of Ivera Medical. "We believe there is value in having our products Made in the USA and feel there is no place for the deception evident in this case. Given the importance many facilities place on buying American-made products, especially in US Government hospitals like the VA and Department of Defense, it is just not acceptable to mislead customers about the manufacture of a product like this."

About Ivera Medical
Ivera Medical Corporation, a certified Minority Business Enterprise (MBE), is focused on the design, development, manufacture, marketing and sale of products that help healthcare providers reduce facility-acquired patient infections. Curos, manufactured in the USA, is the first disinfecting cap to be marketed in the U.S. and has received FDA's 510(k) market clearance. For more information about Curos and Ivera Medical, visit the website at

Matt Heindel
Vice President, Business Development
Ivera Medical Corp.

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.